The income from operations of the firm rose to Rs 436.19 crore during the quarter under review, from Rs 237.24 crore in the year-ago period, Biocon said in a filing to the Bombay Stock Exchange.

Last year in April, Biocon had acquired 71 per cent stake in Germany-based AxiCorp. Accordingly, the consolidated results of Biocon for the nine-month ended December 2008 include the results of Axicorp for the period from April 1 to September 30, 2008, the filing said.

On a standalone basis, the Bangalore-based Biopharma company reported a net profit of Rs 24.08 crore, while it had a net profit of Rs 284.04 crore in the year-ago period.

Also the standalone income from operations rose to Rs 219.87 crore during the quarter, from Rs 194.19 crore in the same period last fiscal.

For the nine month ended December 2008, Biocon reported a consolidated net profit of Rs 68.24 crore, while it had a net loss of Rs 388.56 crore in the same period last fiscal.